about
P1343
Hepatoblastoma: A Need for Cell Lines and Tissue Banks to Develop Targeted Drug TherapiesTargeting the Wnt/β-catenin signaling pathway in liver cancer stem cells and hepatocellular carcinoma cell lines with FH535The Human NADPH Oxidase, Nox4, Regulates Cytoskeletal Organization in Two Cancer Cell Lines, HepG2 and SH-SY5Y.Effects of octreotide on hepatic glycogenesis in rats with high fat diet‑induced obesity.Characterisation of the cell line HC-AFW1 derived from a pediatric hepatocellular carcinoma.Identification of T-cell factor-4 isoforms that contribute to the malignant phenotype of hepatocellular carcinoma cells.Identification of a unique hepatocellular carcinoma line, Li-7, with CD13(+) cancer stem cells hierarchy and population change upon its differentiation during culture and effects of sorafenib.IGFBP3 impedes aggressive growth of pediatric liver cancer and is epigenetically silenced in vascular invasive and metastatic tumorsInterleukin-6 and oncostatin M are elevated in liver disease in conjunction with candidate hepatocellular carcinoma biomarker GP73.Effects of curcumin in pediatric epithelial liver tumors: inhibition of tumor growth and alpha-fetoprotein in vitro and in vivo involving the NFkappaB- and the beta-catenin pathways.IF-combined smRNA FISH reveals interaction of MCPIP1 protein with IER3 mRNA.Berberine Suppresses Cyclin D1 Expression through Proteasomal Degradation in Human Hepatoma Cells.Suppression of KIF3B expression inhibits human hepatocellular carcinoma proliferation.Golgi apparatus dis- and reorganizations studied with the aid of 2-deoxy-D-glucose and visualized by 3D-electron tomography.A mutant of hepatitis B virus X protein (HBx Delta 127) enhances hepatoma cell migration via osteopontin involving 5-lipoxygenase.Natural compounds for pediatric cancer treatment.Epigallocatechin-3-gallate inhibits hepatoblastoma growth by reactivating the Wnt inhibitor SFRP1.Positive Feedback Loop of OCT4 and c-JUN Expedites Cancer Stemness in Liver Cancer.High expression FUT1 and B3GALT5 is an independent predictor of postoperative recurrence and survival in hepatocellular carcinoma.Angelicin inhibits liver cancer growth in vitro and in vivo.Central role of mTORC1 downstream of YAP/TAZ in hepatoblastoma development.Alcohol dehydrogenase and cytochrome P450 2E1 can be induced by long-term exposure to ethanol in cultured liver HEP-G2 cells.A clinical-scale BioArtificial Liver, developed for GMP, improved clinical parameters of liver function in porcine liver failure.Epigenetic analysis of FHL1 tumor suppressor gene in human liver cancer.Hypoxia induces the expression of TET enzymes in HepG2 cells.Synergistic effect of nutlin-3 combined with aspirin in hepatocellular carcinoma HepG2 cells through activation of Bcl-2/Bax signaling pathway.Mechanism of Astragalus polysaccharides in attenuating insulin resistance in Rats with type 2 diabetes mellitus via the regulation of liver microRNA‑203a‑3p.Low dosage of arsenic trioxide inhibits vasculogenic mimicry in hepatoblastoma without cell apoptosis.Sphingomyelin synthase 2 overexpression promotes cisplatin-induced apoptosis of HepG2 cells.In vitro modeling of hepatocellular carcinoma molecular subtypes for anti-cancer drug assessment.CXCL5 as an autocrine or paracrine cytokine is associated with proliferation and migration of hepatoblastoma HepG2 cells.Antitumor and immunostimulatory activities of a genotype V recombinant attenuated veterinary Newcastle disease virus vaccine.Effects of ginkgol C17:1 on cisplatin-induced autophagy and apoptosis in HepG2 cells.Propranolol suppresses the proliferation and induces the apoptosis of liver cancer cells.RASAL1 inhibits HepG2 cell growth via HIF-2α mediated gluconeogenesis.GTSF1 gene may serve as a novel potential diagnostic biomarker for liver cancer.Mitochondrial ROS contribute to oridonin-induced HepG2 apoptosis through PARP activation.DEPDC7 inhibits cell proliferation, migration and invasion in hepatoma cells.3D-cultured adipose tissue-derived stem cells inhibit liver cancer cell migration and invasion through suppressing epithelial-mesenchymal transition.Pine needle oil induces G2/M arrest of HepG2 cells by activating the ATM pathway.
P2860
Q26751517-83BF4CAA-A855-4DD3-81AA-B39315BE3645Q27324314-838DEF2F-D55D-48E0-9F19-1E9E30B488BBQ33740602-081DF18A-9DA8-4033-A7D5-63D9F00C625CQ33828131-AFD559A3-8D38-48D3-8483-79B3DAD378D8Q34292958-ED4E7A41-5D35-4455-BCD3-A26EC7DCFE43Q34732789-7951A948-62ED-46ED-9781-4FEDFB029848Q35410105-4504066C-F39D-4006-B621-FD859AD76EA8Q35951090-0CF4E3BE-9410-49E9-9008-2A8FB0736504Q36393694-492A98E1-E47E-4295-8D9F-6C54F0774BF0Q36562132-84A52A3B-6C14-4839-B9A6-471F5884669EQ37120304-7B97A517-FC3F-4627-98DE-A84B5E661683Q37465622-35AA81E5-22AC-4592-8C81-DC4FC2CBF187Q37644935-9F2BE633-469F-4A85-9A4E-767CD419323FQ37712748-4569A7D3-067E-42F3-920E-2979639E1EBEQ37728807-E6B7D79E-D5DA-4700-BB15-AC852A640A1CQ38663897-FE46E746-063E-44AA-8054-F01F4B83BDB1Q39078216-C2753ABE-3014-4254-810F-631620C6B21FQ40637784-23FBA570-2931-4629-A6FC-C9E38B498D59Q41544461-F58E609B-EDAA-4CF3-A9DB-188102A691B6Q42678924-4D53A083-6933-4F33-8EAD-580A4C9B5C83Q43088347-9979D1AE-5414-404B-826D-0697453A2AB8Q45374266-7CB754C1-F7E3-450E-950E-F7B214195E53Q45978445-1812E6BE-8A9F-4068-8ADE-92EB7CDB8274Q47129854-B99C74E8-58E8-4E73-9292-0CFAE240BF59Q47146112-2122E622-CCC8-4FE4-9D3E-1B827152EEA5Q47246445-3ABB931E-97EE-431E-8D45-062EFF379D1DQ47276406-41CE2AE4-22FB-4FE3-BC0C-BF0509FD7D85Q47401268-DC4A7609-A677-4413-AAC1-64ACF0262242Q47548468-743EC413-DF5B-4EE8-874E-F7D48BE0EBB9Q48304356-AFC0BAA1-7EBA-46F4-B345-EE7B3CB629DBQ49268237-39ACC44E-39D1-4928-85E0-49A060FC4910Q49334996-ED7661C5-8BFF-4984-BD72-C0E1E4356557Q49335119-17016139-A7F9-43D7-B9E4-77243EF2F9F9Q49379372-A364A260-2E01-44FC-B4E2-9377186E6285Q49414860-A9E03DFC-106D-472B-9C29-B2DDC98D8B4EQ49431252-3BA18980-8F8B-4FCB-9EEB-58E660F378B5Q49460838-B54304A9-76C4-42DB-857C-91610744FBFFQ49493874-69BB212D-00B0-4321-BC01-FA8BEFF1635FQ49501063-212DC24F-7B35-48A0-8543-354B5284E7DBQ49706343-25CAB94B-2881-4CA3-A29C-06CE1CB0E6F9
P2860
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Hep G2 is a hepatoblastoma-derived cell line.
@en
Hep G2 is a hepatoblastoma-derived cell line.
@nl
type
label
Hep G2 is a hepatoblastoma-derived cell line.
@en
Hep G2 is a hepatoblastoma-derived cell line.
@nl
prefLabel
Hep G2 is a hepatoblastoma-derived cell line.
@en
Hep G2 is a hepatoblastoma-derived cell line.
@nl
P2093
P1433
P1476
Hep G2 is a hepatoblastoma-derived cell line
@en
P2093
Dolores López-Terrada
Milton J Finegold
Sau Wai Cheung
P304
P356
10.1016/J.HUMPATH.2009.07.003
P407
P4510
P577
2009-10-01T00:00:00Z